We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biovail Sues Impax Over Generic Wellbutrin XL
Biovail Sues Impax Over Generic Wellbutrin XL
March 22, 2005
Biovail Laboratories has filed a lawsuit in federal court against generic firm Impax over its bid to launch a generic version of Biovail’s Wellbutrin XL, an antidepressant marketed by GlaxoSmithKline.